Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.
NCT ID: NCT04245930
Last Updated: 2020-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
176 participants
INTERVENTIONAL
2020-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Mesh Used in Two-staged Breast Reconstruction
NCT04967976
Pre-pectoral Breast Reconstruction With or Without Mesh
NCT05888571
Prepectoral and Subpectoral Implant-based Breast Reconstruction
NCT04688697
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
NCT02562170
Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)
NCT03589924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bovine Pericardial Patch
Immediate implant breast reconstruction using bovine pericardial patch. n=88
Bovine Pericardial Patch in Immediate Implant Breast Reconstruction
Patients will receive immediate breast implant reconstruction using Bovine Pericardial Patch
TiLOOP® Bra Mesh
Immediate implant breast reconstruction using TiLOOP® Bra Mesh. n=88
TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction
Patients will receive immediate breast implant reconstruction using TiLOOP® Bra Mesh
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bovine Pericardial Patch in Immediate Implant Breast Reconstruction
Patients will receive immediate breast implant reconstruction using Bovine Pericardial Patch
TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction
Patients will receive immediate breast implant reconstruction using TiLOOP® Bra Mesh
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Do not smoking in the last 4 weeks or more
3. Mental health patients
4. Signed consent to participate
Exclusion Criteria
2. Patients received thoracic wall radiotherapy or will receive radiotherapy
3. Smoking in the last 4 weeks
4. Anticipated implant volume more than 600cc
5. Patients of pregnancy or lactation
6. Patients received neoadjuvant therapy
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Medical University Cancer Institute and Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jian Yin, MD.
Role: PRINCIPAL_INVESTIGATOR
Tianjin Medical University Cancer Institute and Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E2019453
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.